-
-
-
-
-
-
-
Oncolytics Biotech® Reports Highlights and Financial Results for Q4 and Year-End 2024
-
-
-
-
-
-
-
Oncolytics Biotech® Reports Third Quarter 2023 Financial Results and Operational Highlights
-
-
-
-
-
-
-
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders and Appoints James T. Parsons to its Board of Directors
-
-
-
-
-
-
-
Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling
-
-
-
-
-
-
-
Oncolytics Biotech® Inc. Announces 2017 First Quarter Results
-
-
-
-
-
-
-
Oncolytics Biotech® Inc. Announces 2015 Second Quarter Results
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

